NeoGenomics, Inc. has grown revenue 12% a year over three years and 9.4% a year over five. Revenue growth, 3-year annual rate: +12% (Diagnostics & Research median +9.1%). Revenue growth, 5-year rate: +9.4%, growth has picked up over the last three years. Years of annual history on file: 16, FY2010 to FY2025, as filed.

NEONeoGenomics, Inc.

HealthcareUSD

$17.38

$5.8052 weeks$17.38

Is it growing?

Is NEO growing?

NeoGenomics, Inc. has grown revenue 12% a year over three years and 9.4% a year over five.

+12%

Revenue growth, 3-year annual rate · Diagnostics & Research median +9.1% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +9.4%
Revenue growth, 5-year rate · +12% over three · growth has picked up over the last three years
Years of annual history on file: 16
Years of annual history on file · FY2010 to FY2025, as filed

Details›